On this page
Humatrope
somatropin
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Humatrope
Proper name
somatropin
Licence type
351(a)
BLA number
019640
Applicant
Eli Lilly and Company
Center
CDER
Presentations
5
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 12MG | For Injection | Subcutaneous | Multi-Dose Cartridge | Rx | February 4, 1999 |
| 24MG | For Injection | Subcutaneous | Multi-Dose Cartridge | Rx | February 4, 1999 |
| 2MG | For Injection | Subcutaneous | Single-Dose Vial | Disc | June 23, 1987 |
| 5MG | For Injection | Subcutaneous | Single-Dose Vial | Disc | October 16, 1986 |
| 6MG | For Injection | Subcutaneous | Multi-Dose Cartridge | Rx | February 4, 1999 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | November 1, 2013 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |